Patent Assignment
Reel/Frame 055944/0177
Assignment of Assignor's Interest
Recorded: 2021-04-16
Pages: 6
Assignor
TRIPHASE ACCELERATOR U.S. CORPORATION
Executed: 2020-06-19
Assignee
TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
661 UNIVERSITY AVE., SUITE 415, TORONTO, ONTARIO, M5G 1M1, CANADA
Covered Properties
(3)
Anti-CD22 Antibody-Maytansine Conjugates, Combinations,and Methods of Use Thereof
PCT:
PCT/US2018/064879 ↗
Anti-CD22 Antibody-Maytansine Conjugates, Combinations, and Methods of Use Thereof
Application:
16/216,233 →
Publication:
US 2019/0201541
Anti-CD22 Antibody-Maytansine Conjugates, Combinations, and Methods of Use Thereof
Application:
62/597,160 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 17, 2018
From: MACLAREN, ANN
To: TRIPHASE ACCELERATOR U.S. CORPORATION
Reel/Frame 045085/0529 →
Assignment of Assignor's Interest
Mar 27, 2019
From: MACLAREN, ANN
To: TRIPHASE ACCELERATOR U.S. CORPORATION
Reel/Frame 048712/0691 →
Assignment of Assignor's Interest
May 23, 2023
From: TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 063740/0236 →
Assignment of Assignor's Interest
Jul 10, 2023
From: TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 064197/0253 →
Security Interest
Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →